Encompass Health Corp (HLS):製薬・医療:M&Aディール及び事業提携情報

【英語タイトル】Encompass Health Corp (HLS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C5331)・商品コード:DATA904C5331
・発行会社(調査会社):GlobalData
・発行日:2018年9月
・ページ数:53
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Encompass Health Corp (Encompass Health), formerly HealthSouth Corp is a post-acute healthcare service provider that offers rehabilitation and home based patient care services. The center owns and operates inpatient rehabilitation and hospitals and provides treatment to medical conditions such as diabetes, brain injury, cardiac care, joint replacement, hip fracture, multi trauma, wound care, multi trauma strokes, oncology, pediatrics, neurological disorders, spinal cord injuries, head injuries, and patients requiring rehabilitative healthcare. It offers firm surface services such as non-skid mat on the floor and bed with a very firm mattress, firm chair without wheels, among others. Encompass Health’s inpatient rehabilitation offers rehabilitative care through diagnoses. The center serves people with physical and cognitive disabilities. Encompass Health is headquartered in Birmingham, Alabama, the US.

Encompass Health Corp (HLS) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Encompass Health Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Encompass Health Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Encompass Health Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Encompass Health Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Encompass Health Corp, Medical Devices Deals, 2012 to YTD 2018 10
Encompass Health Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Encompass Health Corp, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Encompass Home Health Acquires Home Health Agency Operations from CareSouth Health System for USD170 Million 12
HealthSouth Acquires Cardinal Hill Rehabilitation Hospital from Kentucky Easter 13
HealthSouth Completes Acquisition Of Walton Rehabilitation Hospital From Walton Rehabilitation Health System 14
HealthSouth Acquires Adult Inpatient Rehabilitation Unit From Christus Santa Rosa Hospital 15
Partnerships 16
HealthSouth to Form Joint Venture with St. John Health System 16
HealthSouth to Form Joint Venture with Mount Carmel Health 17
West Tennessee Healthcare to Form Joint Venture with HealthSouth 18
HealthSouth to Form Joint Venture with Memorial Health 19
Debt Offering 20
HealthSouth Prices Private Placement of 5.75% Senior Notes due 2024 for USD350 Million 20
HealthSouth Raises USD300 Million in Public Offering of 5.125% Notes Due 2023 21
HealthSouth Completes Public Offering of 5.75% Notes Due 2024 for USD400 Million 23
HealthSouth Raises USD175 Million in Public Offering of 5.75% Notes Due 2024 25
HealthSouth Completes Public Offering Of Notes Due 2024 For US$275 Million 27
Acquisition 29
HealthSouth to Acquire Reliant Hospital for USD730 Million 29
HealthSouth Acquires Encompass Home Health for USD760 Million 31
HealthSouth Acquires Additional 30% Stake in Fairlawn Hospital 33
Encompass Health Corp – Key Competitors 34
Encompass Health Corp – Key Employees 35
Encompass Health Corp – Locations And Subsidiaries 36
Head Office 36
Other Locations & Subsidiaries 36
Recent Developments 39
Strategy And Business Planning 39
Feb 13, 2017: HealthSouth Announces Plans To Build Inpatient Rehabilitation Hospital Serving Hilton Head And Surrounding Counties In South Carolina 39
Financial Announcements 40
Jul 25, 2018: Encompass Health reports results for second quarter 2018 and updates full-year 2018 guidance 40
Oct 26, 2017: HealthSouth Reports Results for Third Quarter 2017 and Updates Full-Year 2017 Guidance 42
Jul 31, 2017: HealthSouth Reports Results for Second Quarter 2017 and Updates Full-Year 2017 Guidance 44
Apr 27, 2017: HealthSouth Reports Strong Revenue and Earnings Growth for First Quarter 2017 and Reiterates Full-Year 2017 Guidance 46
Feb 21, 2017: HealthSouth Reports Strong Revenue and Earnings Growth for Fourth Quarter 2016 and Reiterates Full-Year 2017 Guidance 48
Corporate Communications 50
Dec 11, 2017: HealthSouth Appoints Nancy M. Schlichting to Board of Directors 50
Other Significant Developments 51
Jan 02, 2018: HealthSouth Corporation Completes Planned Corporate Name Change To Encompass Health; Company To Begin Trading On NYSE Under Ticker Symbol EHC 51
Jul 10, 2017: HealthSouth Announces Planned Name Change to Encompass Health Corporation 52
Appendix 53
Methodology 53
About GlobalData 53
Contact Us 53
Disclaimer 53

List of Tables
Encompass Health Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Encompass Health Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Encompass Health Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Encompass Health Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Encompass Health Corp, Deals By Therapy Area, 2012 to YTD 2018 9
Encompass Health Corp, Medical Devices Deals, 2012 to YTD 2018 10
Encompass Health Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Encompass Home Health Acquires Home Health Agency Operations from CareSouth Health System for USD170 Million 12
HealthSouth Acquires Cardinal Hill Rehabilitation Hospital from Kentucky Easter 13
HealthSouth Completes Acquisition Of Walton Rehabilitation Hospital From Walton Rehabilitation Health System 14
HealthSouth Acquires Adult Inpatient Rehabilitation Unit From Christus Santa Rosa Hospital 15
HealthSouth to Form Joint Venture with St. John Health System 16
HealthSouth to Form Joint Venture with Mount Carmel Health 17
West Tennessee Healthcare to Form Joint Venture with HealthSouth 18
HealthSouth to Form Joint Venture with Memorial Health 19
HealthSouth Prices Private Placement of 5.75% Senior Notes due 2024 for USD350 Million 20
HealthSouth Raises USD300 Million in Public Offering of 5.125% Notes Due 2023 21
HealthSouth Completes Public Offering of 5.75% Notes Due 2024 for USD400 Million 23
HealthSouth Raises USD175 Million in Public Offering of 5.75% Notes Due 2024 25
HealthSouth Completes Public Offering Of Notes Due 2024 For US$275 Million 27
HealthSouth to Acquire Reliant Hospital for USD730 Million 29
HealthSouth Acquires Encompass Home Health for USD760 Million 31
HealthSouth Acquires Additional 30% Stake in Fairlawn Hospital 33
Encompass Health Corp, Key Competitors 34
Encompass Health Corp, Key Employees 35
Encompass Health Corp, Other Locations 36
Encompass Health Corp, Subsidiaries 36

List of Figures
Encompass Health Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Encompass Health Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Encompass Health Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Encompass Health Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Encompass Health Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Encompass Health Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Encompass Health Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Encompass Health Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Encompass Health Corp, Medical Devices Deals, 2012 to YTD 2018 10

★調査レポート[Encompass Health Corp (HLS):製薬・医療:M&Aディール及び事業提携情報] (コード:DATA904C5331)販売に関する免責事項を必ずご確認ください。
★調査レポート[Encompass Health Corp (HLS):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆